| Clave |
101786 |
| Nombre del Modulo |
1.1.1.1 Cursos a Nivel de Licenciatura |
| Tipo de Curso |
Laboratorio |
| Trimestre Lectivo |
09/O |
| Coeficiente de Participacion |
History <a href=" https://moultonstudio.com/elegant-artificial-flowers-for-all-seasons/ ">lamotrigine 100 mg pill identifier</a> AstraZeneca has accused its South Korean rival of patent infringement for developing Esomezol, a drug that treats gastroesoph |
| Numero de Horas |
History <a href=" https://moultonstudio.com/elegant-artificial-flowers-for-all-seasons/ ">lamotrigine 100 mg pill identifier</a> AstraZeneca has accused its South Korean rival of patent infringement for developing Esomezol, a drug that treats gastroesoph |
| Grupo |
History <a href=" https://moultonstudio.com/elegant-artificial-flowers-for-all-seasons/ ">lamotrigine 100 mg pill identifier</a> AstraZeneca has accused its South Korean rival of patent infringement for developing Esomezol, a drug that treats gastroesoph |
| Observaciones |
History <a href=" https://moultonstudio.com/elegant-artificial-flowers-for-all-seasons/ ">lamotrigine 100 mg pill identifier</a> AstraZeneca has accused its South Korean rival of patent infringement for developing Esomezol, a drug that treats gastroesoph |
| Descripcion |
History <a href=" https://moultonstudio.com/elegant-artificial-flowers-for-all-seasons/ ">lamotrigine 100 mg pill identifier</a> AstraZeneca has accused its South Korean rival of patent infringement for developing Esomezol, a drug that treats gastro |
| U.E.A. |
INTERVENCIÓN PSICOSOCIAL: GRUPAL, INSTITUCIONAL Y COMUNITARIA II |
320159 |
| Número Económico |
0 |
| Fecha de registro |
2018-11-23 16:50:51 |